Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier le Mans

About this trial

In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth.

In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital.

Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route.

Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

patient in intensive care, intubated, ventilated

Adult

Requiring a gastric tube

With an expected duration of mechanical ventilation of more than 48 hours

Disqualifiers

Pregnant, breast-feeding or parturient women

Patients under legal protection: curatorship and guardianship

Contraindication to placing a gastric tube through the nose or mouth

Patients who already have a gastric tube when they enter the service

Trial design

Design model

Crossover

Treatments tested in this trial

  • nasogastric tube and orogastric tube

    Other intervention

    nasogastric tube in period 1 and orogastric tube in period 2

  • orogastric tube and nasogastric tube

    Other intervention

    orogastric tube in period 1 and nasogastric tube in period 2

Treatment groups

2,400 Participants
are divided into 2 treatment groups
Group A: NasogastricExperimental treatment 1 intervention
Group B: OrogastricExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Compare impact of insertion site of gastric tube on the incidence of ventilator associated pneumoniae

The impact is measured by the number of ventilator associated peumonia

Time frame
Day 28

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: